Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR trial of delayed-release colesevelam for bile acid diarrhoea
2025-523868-20-00Phase 2Authorised
- Sponsor
- Monte Research
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Bile acid diarrhea (BAD) comparing SUB01423MIG delayed-release colesevelam with Matching placebo (2 arms). Primary endpoint: BAD remission at end of stable dose treatment period. Planned start Sep 2026; status: authorised.
02
Drugs
SUB01423MIG
03
Conditions
Bile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2025-523868-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523868-20-00.